Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda crawled date : 2022 - 01 - 20 save search
Eargo Applauds Proposed Rule for OTC Hearing Aids and Submits Public Comments to FDA
Published: 2022-01-20 (Crawled : 21:00) - globenewswire.com
EAR | $2.57 7.78% 200K
|
Health Technology
|
| O: -2.85%
H: 3.43%
C: -3.56%
fda
Kura Oncology Receives FDA Authorization to Proceed with Phase 1b Study of KO-539 in Acute Myeloid Leukemia
Published: 2022-01-20 (Crawled : 21:00) - globenewswire.com
KURA | News | $18.74 3.02% 2.93% 1M
|
Health Technology
|
| O: -8.37%
H: 0.0%
C: 0.0%
ko-539 fda myeloid leukemia phase 1b leukemia phase 1 authorization acute myeloid leukemia phase 2b
BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001
Published: 2022-01-20 (Crawled : 20:00) - biospace.com/
BETRF | $0.0745 -3.71% 550
|
Health Technology
|
| O: 5.15%
H: 0.57%
C: -3.86%
betr-001 treatment fda order application response fda response pons major depressive disorder
Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for Combination of Elzovantinib and Aumolertinib in EGFR Mutant Met-Amplified Non-Small Cell Lung Cancer
Published: 2022-01-20 (Crawled : 19:00) - biospace.com/
TPTX | $76.01 -0.03%
|
Health Technology
|
| O: 3.8%
H: 3.32%
C: -5.27%
new drug fda clearance application drug therapeutics cel fda clearance lung cancer cancer
Aptorum Group Receives FDA Orphan Drug Designation for its SACT-1 Repurposed Drug For The Treatment of Neuroblastoma
Published: 2022-01-20 (Crawled : 13:30) - biospace.com/
APM | $5.37 -5.12% -5.6% 35K
|
Health Technology
|
| O: 29.51%
H: 10.13%
C: 6.96%
treatment fda drug orphan drug repurposed group designation
Cardiovascular Systems, Inc. and OrbusNeich Announce FDA PMA Approval of Scoreflex® Scoring Balloon
Published: 2022-01-20 (Crawled : 13:00) - biospace.com/
CSII | $20.0 -0.05% 400K
|
Health Technology
|
| O: -1.0%
H: 5.75%
C: 0.84%
scoreflex fda cardio approval system cardiovascular
CASI PHARMACEUTICALS PARTNER, BIOINVENT, ANNOUNCES BI -1206 GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA FOR THE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA
Published: 2022-01-20 (Crawled : 13:00) - biospace.com/
CASI | $2.42 -0.41% -0.41% 12K
|
Health Technology
|
| O: 2.22%
H: 7.03%
C: -4.69%
treatment fda als drug granted orphan drug designation
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-868 for the Treatment of Advanced Solid Tumors
Published: 2022-01-20 (Crawled : 12:30) - prnewswire.com
NUVB | $2.68 0.0% 880K
|
|
| O: 3.55%
H: 10.11%
C: 1.26%
nuv-868 new drug treatment fda clearance solid tumors application drug fda clearance
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.